source
- CMS proposes rule to close Medicare negotiation loophole for biologicsCMS announced a proposed policy change that would clarify how the Centers for Medicare & Medicaid Services groups products for price negotiations under the Inflation Reduction Act. The rule target…
- FDA says it will maintain Makary’s focus on clinical trials, rare diseases and China despite leadership exitsThe Food and Drug Administration announced that, even after the recent resignations of Commissioner Marty Makary and the heads of its drug and biologics centers, it will keep pursuing the policy ag…